14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MATR vs MMSI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Merit Medical Systems Inc (MMSI) is the stronger overall head-to-head candidate over MATR (MATR) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MATR carries a Unified Composite Score of 47.4/100 (HOLD) at $26.23 (N/M Forward P/E, N/A operating margin), whereas MMSI carries 61.4/100 (BUY) at $86.35 (18.5x Forward P/E, 13.9% operating margin).
Technical & Structure Timing Caution: MATR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile MMSI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MATR vs MMSI. Trailing 12-month operating profitability (MATR N/A vs MMSI 13.9%) and valuation multiples (MATR N/M vs MMSI 18.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Instruments & Supplies value chain with $5.2B market capitalization and 13.9% operating margin.
OpEx & R&D Reinvestment35.1% of Rev ($565M)
90D Engineering Disclosures0 Published
Investor FAQ MATR vs MMSI Key Questions & Quantitative Answers
As of Nov 16, 2026, Merit Medical Systems Inc (MMSI) is the stronger overall head-to-head candidate over MATR (MATR) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MATR carries a Unified Composite Score of 47.4/100 (HOLD) at $26.23 (N/M Forward P/E, N/A operating margin), whereas MMSI carries 61.4/100 (BUY) at $86.35 (18.5x Forward P/E, 13.9% operating margin). Technical & Structure Timing Caution: MATR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile MMSI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MMSI leads the Growth & Scale pillar: MATR posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with MMSI at +8.4% YoY revenue growth and +52.2% YoY earnings growth on $1.61B TTM revenue (49.0% gross margin, 13.9% operating margin). On trailing 12-month operating scale, MATR generates N/A in USD-normalized revenue versus $1.61B for MMSI. In operating R&D and SG&A reinvestment, MATR deploys N/A (0 90-day corporate R&D disclosures) versus 35.1% of Rev ($565M) (0 disclosures) for MMSI.
MMSI screens cheaper on headline valuation multiples. MATR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MMSI trades at 18.5x Forward P/E, 32.5x Trailing P/E, 1.54x PEG, and 3.2x EV/Revenue (21.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MATR (N/A ROE) versus MMSI (9.8% ROE) capital efficiency.
In options market volatility and institutional positioning, MATR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 19% Vol realized risk). By comparison, MMSI carries 30.9% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 44% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.